TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL Other Scholarly Work

Ahluwalia, MS, Khosla, AA, Ozair, A et al. (2023). TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL . NEURO-ONCOLOGY, 25 10.1093/neuonc/noad137.028

Open Access

cited authors

  • Ahluwalia, MS; Khosla, AA; Ozair, A; Kotecha, RR; McDermott, MW; Mehta, MP; Sandoval-Leon, AC; Mahtani, R; Peereboom, DM

publication date

  • September 1, 2023

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • NETHERLANDS, Rotterdam

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

volume

  • 25